Myasthenia Gravis
Newsletter Donate   
Myasthenia Gravis on Twitter Myasthenia Gravis on Facebook Myasthenia Gravis on YouTube
  • Clinical Trials
Myasthenia Gravis on Twitter Myasthenia Gravis on Facebook Myasthenia Gravis on YouTube

Donate

Sign Up

  • Home
  • About MG
    • What is MG?
    • Life with MG
    • Diagnosis
    • Symptoms
    • What Makes MG Better
    • What Makes MG Worse
    • Myasthenia Gravis Questions
    • MG Terms
  • Get Involved
    • Events
      • Fall Resource Fair
      • Webinars & Educational Events
      • Living with MG: Video Education Series
      • Snowflake Shuffle for MG
      • Spring Resource Fair
    • Advocacy Toolkit
    • Our Partners
      • Alexion and Conquer MG
      • argenx and Conquer MG
    • Donate to the Cause
  • Get Support
    • Direct Patient Assistance Program
    • Support Groups
    • Clinical Trials
    • News & Stories
    • Sign-up
    • Read Newsletters
    • Other Resources
  • About Conquer MG
    • Mission and History
    • Contact
    • What We Do
    • For the Media
    • Medical Advisory Board
    • Board of Trustees and Staff
  • Increase Text Size

September 2019 drugs to avoid

Posted March 22, 2021

September 2019 drugs to avoid

Filed under:

Recent Posts

  • Advancing MG Research: From Discovery to What’s Next
  • 2026 Snowflake Shuffle Recap!
  • argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
  • Monica Seles Speaks Out About Living with Myasthenia Gravis and partners with argenx in the Go for Greater initiative
  • Argenx announces innovative pre-filled syringe self-injection option for adults with gMG

Blog Archives

  • August 2026
  • June 2026
  • May 2026
  • August 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • June 2024
  • April 2024
  • September 2023
  • May 2023
  • February 2023
  • December 2022
  • October 2022
  • September 2022
  • July 2022
  • April 2022
  • January 2022
  • July 2021
  • May 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • March 2019
  • February 2019
  • December 2018
  • September 2018
  • March 2018
  • February 2018
  • December 2017
  • August 2017
  • June 2017
  • May 2017
  • January 2017
  • September 2016
  • August 2016
  • June 2016
  • March 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • March 2015
  • February 2015
  • January 2015

Partners and Friends of Conquer MG

argenx
Alexion Pharmaceuticals
Amgen
MG Alliance

Conquer Myasthenia Gravis
4055 W. Peterson Ave. Suite 105
Chicago, IL 60646

info@myastheniagravis.org

(800) 888-6208

  • Home
  • About Myasthenia Gravis
  • Life with MG
  • We Can Help
  • Research
  • About Us
  • Donations
  • Contact

© 2026 Conquer Myasthenia Gravis
Privacy Policy - Disclaimer - Site Map

  • Home
  • About MG
    • What is MG?
    • Life with MG
    • Diagnosis
    • Symptoms
    • What Makes MG Better
    • What Makes MG Worse
    • Myasthenia Gravis Questions
    • MG Terms
  • Get Involved
    • Events
      • Fall Resource Fair
      • Webinars & Educational Events
      • Living with MG: Video Education Series
      • Snowflake Shuffle for MG
      • Spring Resource Fair
    • Advocacy Toolkit
    • Our Partners
      • Alexion and Conquer MG
      • argenx and Conquer MG
    • Donate to the Cause
  • Get Support
    • Direct Patient Assistance Program
    • Support Groups
    • Clinical Trials
    • News & Stories
    • Sign-up
    • Read Newsletters
    • Other Resources
  • About Conquer MG
    • Mission and History
    • Contact
    • What We Do
    • For the Media
    • Medical Advisory Board
    • Board of Trustees and Staff
  • Clinical Trials
Verified by MonsterInsights